Study protocol: multicenter double-blind, randomized, placebo-controlled trial of rituximab for the treatment of childhood-onset early-stage uncomplicated frequently relapsing or steroid-dependent nephrotic syndrome (JSKDC10 trial)
暂无分享,去创建一个
K. Nakanishi | Hidefumi Nakamura | T. Omori | K. Nozu | K. Iijima | K. Kamei | K. Ishikura | M. Sako | C. Nagano